CD45RO Monoclonal Antibody (UCHL1), FITC, eBioscience™, Invitrogen™

Description

• Description: The UCHL1 monoclonal antibody reacts with human CD45RO, a 180 kDa isoform of CD45
• CD45RO is expressed by most thymocytes, activated memory T cells, granulocytes and monocytes
• CD22 is a ligand for CD45RO
• Expression of CD45RO and CD45RA is used commonly to discriminate subsets of peripheral T cells
• Applications Reported: The UCHL1 antibody has been reported for use in flow cytometric analysis
• Applications Tested: This UCHL1 antibody has been pre-titrated and tested by flow cytometric analysis of normal human peripheral blood cells
• This can be used at 5 μL (0.5 μg) per test
• A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
• Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
• Excitation: 488 nm; Emission: 520 nm; Laser: Blue Laser
• Filtration: 0.2 μm post-manufacturing filtered
• CD45RO (UCHL1, ubiquitin carboxyl terminal esterase L1) is the shortest isoform of a receptor-type protein tyrosine phosphatase, CD45 glycoprotein
• CD45 is crucial in lymphocyte development and antigen signaling, serving as an important regulator of Src-family kinases, promotes cell survival by modulating integrin-mediated signal transduction pathway and is also involved in DNA fragmentation during apoptosis
• CD45 isoforms differ in their extracellular domains, whereas they share identical transmembrane and cytoplasmic domains
• CD45 isoforms differ in their ability to translocate into the glycosphingolipid-enriched membrane domains and their expression depends on cell type and physiological state of the cell
• CD45RO is expressed on macrophages, CD8+ T cells, activated T cells and myeloma cells
• Besides the role in immunoreceptor signaling, CD45 is important in promoting cell survival by modulating integrin-mediated signal transduction pathway and is also involved in DNA fragmentation during apoptosis.